FDA Expands Benralizumab Use for Asthma to Kids Over Age 6 FDA Expands Benralizumab Use for Asthma to Kids Over Age 6

The maintenance treatment for severe asthma with an eosinophilic phenotype originally was approved for patients aged 12 years and older.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pediatrics News Alert Source Type: news